Photochromic heteroarylethenes with fast thermal isomerization kinetics

Stilbenes (diphenylethenes) are fully examined organic chromophores for very diverse applications. However, these molecules might show poor stability under irradiation because several simultaneous reactions (oxidative photocyclization and dimerization) can take place during the photochemical isomerization of their Cdouble bondC bond. In this context, heteroarylethenes emerge as powerful counterparts thanks to their improved stability. In addition, the chosen heterocycles and their functionalization allows to fine tune and increase the speed at which the thermal back reaction occurs, broadening the scope of application of the resulting chromophores. Here we report on the thermal Z-to-E isomerization kinetics of a series of rationally designed heteroarylethenes and how the chemical architecture of the chromophore modulates the speed of the process. Specifically, the metastable Z isomers display relaxation times covering a wide time window, from a few hours to hundreds of microseconds. In fact, one of the studied dyes is the fastest photochromic switch based on heteroarylethenes. It should be also noticed that the described heteroarylethenes exhibit great photochemical stability, it being possible to switch them back and forth many times without degradation

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

Objectives: We utilized the database of the Defining Antibiotic Levels in Intensive care unit patients (DALI) study to statistically compare the pharmacokinetic/pharmacodynamic and clinical outcomes between prolonged- infusion and intermittent-bolus dosing of piperacillin/tazobactam and meropenem in critically ill patients using inclusion criteria similar to those used in previous prospective studies. Methods: This was a post hoc analysis of a prospective, multicentre pharmacokinetic point-prevalence study (DALI), which recruited a large cohort of critically ill patients from 68 ICUs across 10 countries. Results: Of the 211 patients receiving piperacillin/tazobactam and meropenem in the DALI study, 182 met inclusion criteria. Overall, 89.0% (162/182) of patients achieved the most conservative target of 50% fT 65MIC (time over which unbound or free drug concentration remains above the MIC). Decreasing creatinine clearance and the use of prolonged infusion significantly increased the PTA for most pharmacokinetic/pharmacodynamic targets. In the subgroup of patients who had respiratory infection, patients receiving \u3b2-lactams via prolonged infusion demonstrated significantly better 30 day survival when compared with intermittent-bolus patients [86.2% (25/29) versus 56.7% (17/30); P=0.012]. Additionally, in patients with a SOFA score of 65 9, administration by prolonged infusion compared with intermittent-bolus dosing demonstrated significantly better clinical cure [73.3% (11/15) versus 35.0% (7/20); P=0.035] and survival rates [73.3% (11/15) versus 25.0% (5/20); P=0.025]. Conclusions: Analysis of this large dataset has provided additional data on the niche benefits of administration of piperacillin/tazobactam and meropenem by prolonged infusion in critically ill patients, particularly for patients with respiratory infections. \ua9 The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved